Sudha has over two decades of experience as a researcher and entrepreneur, having co-founded one of India's oldest genomics firm, Genotypic Technologies in the late 90's. She has a PhD in Biotechnology and following her post-doctoral studies in neurobiology at Cornell Medical School, she worked extensively in the identification of genetic suppressor elements.
Her endeavour in setting up a world-class organisation in Genotypic bore fruit when for the first time, a genomics company was awarded the SAP ACE 2010 award for Customer Excellence and Best Run Business for having the foresight to leverage software as a service model to support rapid growth.
Kannan Ramesh has over 25 years of consulting experience in Management, Business, Finance and Strategy with a specialisation in Healthcare Consulting. He has helped several respected names in the healthcare industry to scale-up across multiple areas and geographies.
Some of the healthcare brands with whom he has had a long engagement with include Sahyadri Hospitals, Vikram Hospitals, Image Hospitals HCG ( BIO & Curie ), Indus Health Plus, Jhankaria Imaging ( now SRL), Mallya Hospital, GVN Hospitals, Express Clinics, NU Hospitals, Kosmoderma, VS Hospitals, Sparsh Nephrocare, Cygnus Hospitals, etc.
Prof Samir K Brahmachari is the pioneer of functional genomics in India. He was the Founder-Director of Institute of Genomics and Integrative Biology, New Delhi, prior to which he was a Professor in Molecular Biophysics Unit, Indian Institute of Science, Bangalore.
Prof Brahmachari made fundamental contributions in elucidating the role of repeatitive DNA in genome function using a trans-disciplinary approach, integrating structural biology with genomics, molecular biology and information science. He successfully led the well-recognized Indian Genome Variation Project towards establishing the human genome variation in multi-ethnic, multilingual populations of India as a national resource. Prof Brahmachari mentors Dhiti Omics team in its pursuit to develop affordable and actionable diagnostics by utilizing genomics and computational biology tools.
Meena comes with over 20 years of experience in various domains across technology, business strategy and marketing, having worked in global leadership roles with a number of blue-chip firms across the pharmaceutical and technology industries, like Monsanto, Honeywell, and HCL.
She is a social entrepreneur, having set up niiti consulting (www.niiticonsulting.com) in 2010 to provide strategy and research support to the social sector. She specialises in conceptualising and implementing new initiatives, and has a number of rewards and recognitions under her belt.
Meena has a double Masters' in Biotechnology and Management, a certificate in Social Entrepreneurship from INSEAD and teaches management and entrepreneurship as guest faculty at several Universities in India and abroad.
Honey is an ABMG certified Clinical Molecular Geneticist with experience in developing a niche portfolio of tests for clinical application using multiple technologies, analyzing and interpreting the results to prepare accurate and comprehensive reports. She is a Fellow of the American College of Medical Genetics and holds a NYSDOH Certificate of Qualification in Molecular Genetics.
She has a Bachelor of Science degree in Genetics and a Master of Science degree in Microbiology from Osmania University, Hyderabad, India and earned a PhD in Biotechnology from International Center for Genetic Engineering & Biotechnology and Hamdard University from New Delhi, India. Honey has worked at the Mayo Clinic where she served as Clinical Fellow, Molecular Genetics and Assistant Professor in the Endocrinology Division.
She has also held the position of Clinical Molecular Geneticist and Director of Sales and Marketing at Prevention Genetics, Marshfield USA and is currently VP-Clinical Operations and Laboratory Director at Transgenomic in New Haven, Connecticut.
Dr. Anand has a unique knowledge base, skills and professional experience for over 17 years as a clinician, pathologist and molecular level research scientist both in academia and industry, in USA and India. He completed his M.B.B.S, medical degree from Madras Medical College, Chennai and later completed M.D. in Pathology with a gold medal and honours. He completed training in molecular biology and immunology at premier Institutes in India including All India Institute of Medical Sciences and pursued his postdoctoral research fellowship at Fred Hutchinson Cancer Research Centre, Seattle, USA. His research focused on the immunogenetics of bone marrow transplantation in leukemia patients to identify new genetic markers that can reduce Graft versus Host Disease and increase patient survival. He served as Research Director at Genotypic Technology Pvt Ltd, a leading genomics company in India and worked on many external and internal R &D projects, securing Indo-US research grants, collaborations and worked towards various research & clinical applications of genomics including methodologies like DNA Microarrays, Next Generation Sequencing, Exome sequencing etc.
Dr. Anand's passion has been in correlating clinical, pathological and genetic/ molecular data and bridging the lacunae on each side towards accurate interpretation of novel molecular diagnostic tests and delivering high quality reports for the clinics in the era of personalised/ precision medicine. He has several Original research articles, book chapters, case reports and paper presentations and awards at the International and National level to his credit. He is currently a practising pathologist and Consultant in Molecular Diagnostics & Molecular Pathology with ongoing research in molecular oncology.